scorecardresearch
Tuesday, August 26, 2025
TopicOxford University

Topic: Oxford University

Rs 38 lakh in 3 hours: How rapper & anti-caste activist from Odisha managed his Oxford dream

Sumeet Samos Turuk, a former JNU student, failed to qualify for any of Oxford's scholarships. He then decided to try crowdfunding to finance his dream.

Oxford, Cambridge students raise over Rs 18 lakh for Covid relief in India

Oxford and Cambridge societies have reached one-third of their goal to raise £50,000, which is about Rs 51 lakh, towards Covid relief in India. The joint fundraiser was launched Saturday.

New human challenge trial in UK to study immune response that can prevent Covid reinfection

The human challenge trial by Oxford University researchers will re-infect participants with Covid-19 and will study their immune response before and after the exposure.

Oxford societies claim Rashmi Samant was asked to resign because of views, not religion

Oxford University’s Campaign for Racial Awareness and Equality and Hindu Society have denied Samant’s charge that the institution is intolerant towards Hindus.

Racism now covert, says Indian Oxford student facing backlash over ‘racist’ social media posts

Rashmi Samant, who was set to be Oxford student union president, quit following accusations of being racist. Citing cultural differences, Samant says students need protection from cancel culture.

UK begins trial to test administering both AstraZeneca, Pfizer Covid vaccines to volunteers

Trial led by Oxford University is aimed at checking if mixing two different vaccines could boost efficacy in protecting against different coronavirus strains.

Oxford Covid vaccine might become the first to get Centre’s nod for emergency use

The process of granting emergency use approval for Bharat Biotech's 'Covaxin' may take time as its phase 3 trials are still underway, while Pfizer is yet to make a presentation.

UK says Oxford vaccine review ongoing, won’t be approved until safety, efficacy standards met

UK's Medicines and Healthcare products Regulatory Agency tells ThePrint vaccine review includes poring over pages of lab data. If cleared, it will likely boost chances of the vaccine's approval in India.

AstraZeneca faces more questions on Oxford Covid vaccine after manufacturing error

While AstraZeneca earlier showed 70% efficacy on average in a late-stage study, the scant details released by the UK partners raises doubts on whether US regulators will clear it.

Astra-Oxford delivers on Covid vaccine, but can’t match rivals Pfizer & Moderna

AstraZeneca and Oxford are taking a different vaccine approach from the one used by Pfizer and Moderna. Here's what the results could mean in the battle.

On Camera

India will absorb Trump tariff impact due to its Achilles’ heel

Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

‘Peace without power Utopian, lessons from Op Sindoor being implemented’—CDS inaugurates Ran Samvad

India’s 1st tri-service seminar, on the lines of Shangri-La Dialogue, kicks off in Mhow, with top military officers & defence attaches from several countries in attendance.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.